Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Attack on amyloid.

× No keyword cloud information.

24 in total

Review 1. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans.

Authors: M S Brown; J Ye; R B Rawson; J L Goldstein
Journal: Cell Date: 2000-02-18 Impact factor: 41.582

2. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors: S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal: Nature Date: 2001-11-08 Impact factor: 49.962

Review 3. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

Authors: Dale Schenk
Journal: Nat Rev Neurosci Date: 2002-10 Impact factor: 34.870

4. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Authors: E Masliah; E Rockenstein; I Veinbergs; Y Sagara; M Mallory; M Hashimoto; L Mucke
Journal: Proc Natl Acad Sci U S A Date: 2001-09-25 Impact factor: 11.205

5. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

Authors: Christoph Hock; Uwe Konietzko; Andreas Papassotiropoulos; Axel Wollmer; Johannes Streffer; Ruth C von Rotz; Gabriela Davey; Eva Moritz; Roger M Nitsch
Journal: Nat Med Date: 2002-10-15 Impact factor: 53.440

6. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

Authors: Deniz Kirik; Carl Rosenblad; Corinna Burger; Cecilia Lundberg; Teit E Johansen; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal: J Neurosci Date: 2002-04-01 Impact factor: 6.167

7. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors: C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal: Proc Natl Acad Sci U S A Date: 2002-07-16 Impact factor: 11.205

Review 8. Immunotherapy for Alzheimer's disease.

Authors: Richard C Dodel; Harald Hampel; Yansheng Du
Journal: Lancet Neurol Date: 2003-04 Impact factor: 44.182

9. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

Authors: Benoit I Giasson; John E Duda; Shawn M Quinn; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal: Neuron Date: 2002-05-16 Impact factor: 17.173

10. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors: K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal: J Cell Biol Date: 2002-03-18 Impact factor: 10.539

2 in total

Review 1. Amyloid beta: structure, biology and structure-based therapeutic development.

Authors: Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal: Acta Pharmacol Sin Date: 2017-07-17 Impact factor: 6.150

2. beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptide.

Authors: Paolo Paganetti; Verena Calanca; Carmela Galli; Muriel Stefani; Maurizio Molinari
Journal: J Cell Biol Date: 2005-03-14 Impact factor: 10.539

2 in total